What is Amgen's EBITDA margin?

Latest reported EBITDA margin for Amgen (AMGN) is 46.58% as of the trailing twelve months (TTM) ending March 31, 2026.

How has Amgen EBITDA margin changed year-over-year?

Amgen (AMGN) EBITDA margin changed +3.2 percentage points year-over-year on the latest annual filing.

When did Amgen EBITDA margin hit its highest annual value?

Amgen EBITDA margin reached its highest annual value of 56.27% in 2017.

What was Amgen EBITDA margin in 2024?

Amgen (AMGN) EBITDA margin in 2024 was 39.96%.

What was Amgen EBITDA margin in 2025?

Amgen (AMGN) EBITDA margin in 2025 was 43.12%.

Amgen (AMGN) EBITDA Margin — Annual & Quarterly %

TTM

46.6%

YoY change

+3.16pp

Trough year (1987)

-3.4%

Peak year (2017)

56.3%

EBITDA Margin history chart for Amgen (AMGN) from 1985 to 2025

Latest: 43.1%

EBITDA Margin change chart for Amgen (AMGN) from 1985 to 2025

Latest: +3.16pp

EBITDA Margin history table for Amgen (AMGN) from 1985 to 2025


2025	43.1%	+3.16pp	Dec 31, 2025	Feb 13, 2026
2024	40.0%	-12.55pp	Dec 31, 2024	Feb 14, 2025
2023	52.5%	+6.27pp	Dec 31, 2023	Feb 14, 2024
2022	46.2%	+2.75pp	Dec 31, 2022	Feb 9, 2023
2021	43.5%	-7.64pp	Dec 31, 2021	Feb 16, 2022
2020	51.1%	-2.96pp	Dec 31, 2020	Feb 9, 2021
2019	54.1%	-0.18pp	Dec 31, 2019	Feb 12, 2020
2018	54.3%	-2.01pp	Dec 31, 2018	Feb 13, 2019
2017	56.3%	+1.77pp	Dec 31, 2017	Feb 13, 2018
2016	54.5%	+2.88pp	Dec 31, 2016	Feb 14, 2017
2015	51.6%	+8.01pp	Dec 31, 2015	Feb 16, 2016
2014	43.6%	+3.05pp	Dec 31, 2014	Feb 19, 2015
2013	40.5%	-0.86pp	Dec 31, 2013	Feb 24, 2014
2012	41.4%	+4.06pp	Dec 31, 2012	Feb 27, 2013
2011	37.4%	-8.74pp	Dec 31, 2011	Feb 29, 2012
2010	46.1%	-0.56pp	Dec 31, 2010	Feb 25, 2011
2009	46.7%	+2.40pp	Dec 31, 2009	Mar 1, 2010
2008	44.3%	+3.76pp	Dec 31, 2008	Feb 27, 2009
2007	40.5%	-1.80pp	Dec 31, 2007	Feb 28, 2008
2006	42.3%	-3.48pp	Dec 31, 2006	Feb 28, 2007
2005	45.8%	+1.83pp	Dec 31, 2005	Mar 10, 2006
2004	43.9%	-1.27pp	Dec 31, 2004	Mar 9, 2005
2003	45.2%	-2.84pp	Dec 31, 2003	Mar 11, 2004
2002	48.1%	+3.30pp	Dec 31, 2002	Mar 10, 2003
2001	44.8%	-1.06pp	Dec 31, 2001	Feb 26, 2002
2000	45.8%	-1.05pp	Dec 31, 2000	Mar 7, 2001
1999	46.9%	-0.90pp	Dec 31, 1999	Mar 7, 2000
1998	47.8%	+3.12pp	Dec 31, 1998	Mar 16, 1999
1997	44.7%	-1.58pp	Dec 31, 1997	Mar 24, 1998
1996	46.2%	+1.85pp	Dec 31, 1996	Mar 24, 1997
1995	44.4%	-3.33pp	Dec 31, 1995	Mar 29, 1996
1994	47.7%	+3.29pp	Dec 31, 1994	Mar 30, 1995
1993	44.4%	-4.79pp	Dec 31, 1993	Dec 31, 1993
1992	49.2%	+27.90pp	Dec 31, 1992	Dec 31, 1992
1991	21.3%	-14.82pp	Dec 31, 1991	Dec 31, 1991
1990	36.1%	—	Dec 31, 1990	Dec 31, 1990
1988	4.6%	+7.94pp	Dec 31, 1988	Dec 31, 1988
1987	-3.4%	-7.41pp	Dec 31, 1987	Dec 31, 1987
1986	4.0%	-3.56pp	Dec 31, 1986	Dec 31, 1986
1985	7.6%	—	Dec 31, 1985	Dec 31, 1985

202543.1%+3.16pp
202440.0%-12.55pp
202352.5%+6.27pp
202246.2%+2.75pp
202143.5%-7.64pp
202051.1%-2.96pp
201954.1%-0.18pp
201854.3%-2.01pp
201756.3%+1.77pp
201654.5%+2.88pp
201551.6%+8.01pp
201443.6%+3.05pp
201340.5%-0.86pp
201241.4%+4.06pp
201137.4%-8.74pp
201046.1%-0.56pp
200946.7%+2.40pp
200844.3%+3.76pp
200740.5%-1.80pp
200642.3%-3.48pp
200545.8%+1.83pp
200443.9%-1.27pp
200345.2%-2.84pp
200248.1%+3.30pp
200144.8%-1.06pp
200045.8%-1.05pp
199946.9%-0.90pp
199847.8%+3.12pp
199744.7%-1.58pp
199646.2%+1.85pp
199544.4%-3.33pp
199447.7%+3.29pp
199344.4%-4.79pp
199249.2%+27.90pp
199121.3%-14.82pp
199036.1%—
19884.6%+7.94pp
1987-3.4%-7.41pp
19864.0%-3.56pp
19857.6%—

EBITDA Margin values are taken from Amgen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at Amgen (AMGN)

According to Amgen's latest reported financial statements, the company's latest reported EBITDA margin is 46.6%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending March 31, 2026 (reported April 30, 2026). Chart and table below cover the full reported history back to 1985.

Amgen (AMGN) most recent annual EBITDA margin stands at 43.12% (2025) – expanded 3.2 percentage points year-over-year.

Across the available history, EBITDA margin reached its high of 56.27% in 2017 and its low of -3.39% in 1987.

Amgen EBITDA Margin by Year

Amgen EBITDA Margin 2025: 43.1%

2025's EBITDA margin for Amgen came in at 43.12%, expanded 3.2 percentage points from 2024.

Amgen EBITDA Margin 2024: 40.0%

Amgen posted EBITDA margin of 39.96% in 2024, contracted 12.5 percentage points from 2023.

Amgen EBITDA Margin 2023: 52.5%

In 2023, Amgen reported EBITDA margin of 52.50%, expanded 6.3 percentage points from 2022.

Amgen EBITDA Margin 2022: 46.2%

Amgen EBITDA margin in 2022 was 46.23%, expanded 2.7 percentage points from 2021.

Amgen EBITDA Margin 2021: 43.5%

Amgen EBITDA margin in 2021 was 43.48%.

See more financial history for Amgen (AMGN).

Sector peers by EBITDA Margin

Healthcare peers of Amgen (AMGN), ranked by their latest EBITDA margin


Novo Nordisk (NVO)	55.4%
Eli Lilly (LLY)	45.9%
Merck & Co. (MRK)	34.6%
AstraZeneca (AZN)	33.9%
Johnson & Johnson (JNJ)	30.3%
AbbVie (ABBV)	26.9%
Thermo Fisher Scientific (TMO)	24.7%
UnitedHealth Group (UNH)	5.1%

Frequently asked questions

Amgen (AMGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation